Pharmacology, Toxicology and Pharmaceutical Science
Trastuzumab
100%
X Linked Inhibitor of Apoptosis
100%
Inflammatory Breast Cancer
100%
Inhibitor of Apoptosis Protein
37%
Antiapoptotic
25%
Cell Viability
25%
Procaspase 9
25%
Embelin
25%
Estrogen Receptor
12%
Neoplasm
12%
Epidermal Growth Factor Receptor
12%
Small Interfering RNA
12%
Survivin
12%
Phosphotransferase Inhibitor
12%
Monoclonal Antibody
12%
Epidermal Growth Factor Receptor 2
12%
Neuroscience
Protein Expression
100%
Trastuzumab
100%
X Linked Inhibitor of Apoptosis
100%
Inhibitor of Apoptosis Protein
37%
Cell Viability
25%
Procaspase 9
25%
Estrogen Receptor
12%
Kinase
12%
Monoclonal Antibody
12%
Protein Family
12%
Small Interfering RNA
12%
Epidermal Growth Factor Receptor 2
12%
Epidermal Growth Factor Receptor
12%
Caspase-9
12%
Survivin
12%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Inhibitor of Apoptosis
100%
Trastuzumab
100%
Cell Viability
18%
Epidermal Growth Factor Receptor
18%
Small Molecule
9%
Estrogen Receptor
9%
Kinase
9%
Phosphotransferase
9%
Steady State
9%
Protein Family
9%
Small Interfering RNA
9%
Downregulation
9%
Survivin
9%
Monoclonal Antibody
9%
Caspase-9
9%
Keyphrases
Anti-apoptotic Pathways
25%
Invasive Breast Cancer
12%
Chemotherapy Sensitivity
12%
Therapeutic Monoclonal Antibody
12%
Functional Links
12%
ErbB2 Signaling
12%